Guidelines for the management of asthma in adults: Evidence and recommendations
Issued Date
2022-03-01
Resource Type
ISSN
0125877X
eISSN
22288694
Scopus ID
2-s2.0-85125416282
Pubmed ID
34953479
Journal Title
Asian Pacific Journal of Allergy and Immunology
Volume
40
Issue
1
Start Page
1
End Page
21
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Allergy and Immunology Vol.40 No.1 (2022) , 1-21
Suggested Citation
Kawamatawong T. Guidelines for the management of asthma in adults: Evidence and recommendations. Asian Pacific Journal of Allergy and Immunology Vol.40 No.1 (2022) , 1-21. 21. doi:10.12932/AP-210421-1118 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/85016
Title
Guidelines for the management of asthma in adults: Evidence and recommendations
Author(s)
Other Contributor(s)
Abstract
The multidisciplinary experts in Thailand developed an asthma management recommendation that was relevant to low-middle income countries (LMICS). Population level consideration about asthma management is emphasized. The healthcare systems, access to and availability of treatments as well as the asthma populations vary from country to country in LMICS. The feasibility in clinical practice for implementation is also a major issue. For these reasons, the practice guidelines that are relevant to local contexts are essential to improve better asthma control. Furthermore, integrative and collaboration between asthma experts and the public health sector to implement and discriminate such guidelines will help to achieve these challenging goals. The topics covered include the current asthma situation in Thailand and the Asia-Pacific region, the definition of asthma, asthma diagnosis, assessment of asthma patients, asthma treatment – both pharmacological and non-pharmacological, management of asthma exacerbation, management of asthma comorbidities, treatment of asthma in special conditions, severe and uncontrolled asthma, Thai alternative medicine and asthma, and asthma and coronavirus disease-19 (COVID-19).